In RA patients treated with anti-interleukin-6 receptor antibody (RoActemra) LRG1 was a better marker for remission than CRP, matrix metalloproteinase 3 level and erythrocyte sedimentation rate [54]. The gene discussed is LRG1; the disease is rheumatoid arthritis.